Leave Your Message
ADT1476-Orticumab Biosimilar-(oxLDL)-Research Biosimilar Antibody
Antibody

ADT1476-Orticumab Biosimilar-(oxLDL)-Research Biosimilar Antibody

  • Catalog Number ADT1476
  • Host CHO Cells
  • Species Human
  • Target oxLDL
  • Application ELISA, WB

From selecting the right antibody targets to optimizing expression and purification systems, we work closely with you to develop products that are suitable for your project.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

Oxidized Low-Density Lipoprotein, a modified form of LDL implicated in atherosclerosis. Triggers foam cell formation in arterial walls.

Product Specification

Catalog Number

ADT1476

Product Name

ADT1476-Orticumab Biosimilar-(oxLDL)-Research Biosimilar Antibody

Clonity

Monoclonal

Alternate Names

anti-mouse oxLDL antibody,  anti-oxLDL antibody,  anti oxLDL antibody,  recombinant oxLDL,  oxLDL antibody,  anti-oxLDL monoclonal antibody,  oxLDL antibodies,  oxLDL recombinant antibody,  oxLDL blocking antibody

Alias

BI-204,  MLDL-1278A,  R-7418

Host

CHO Cells

Species

Human

Target

oxLDL

Isotype

IgG1 Lambda

Size

100ug, 1mg, 5mg

Research Area

Immunology

CAS Number

1314241-10-5

Product Description

Orticumab (INN) is a human monoclonal antibody that is used as an anti-inflammatory agent and binds to oxLDL. It acts as an immunomodulator.

Application

ELISA, WB

Purity

>95% as determined by SDS-PAGE

Concentration

batch dependent

Buffer

Supplied in PBS,  PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only.